ANDE Stock

ande.comHealthcare / BioTech & PharmaFounded: 2004Funding to Date: $128.92MM

ANDE is the developer of rapid DNA analysis technology designed to help reduce crime, exonerate innocent, monitor borders, and reunite families.

Register for Details

For more details on financing and valuation for ANDE, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for ANDE.

Register Today

ANDE investors also invested in these private companies

Eastward Capital Partners
MassVentures

Team

Management Team

John Rose
Chief Financial Officer
George Heinrichs
Chief Executive Officer & Board Member
Richard Selden
Founder, Chairman & Chief Scientific Officer
Mary Consalvi
General Counsel

Board Members

David Kronfeld
ANDE
Beth Kronfeld
ANDE
George Heinrichs
ANDE
Richard Selden
ANDE

Other companies like ANDE in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B
Sector
Last Round Est. Valuation
$405.17MM

News Highlights

ANDE Introduces Next Generation Hydrocarbon Testing Solution
ANDE Corporation, the global leader in Rapid DNA, announced the immediate availability of the F7-Chip
Updated on: Sep 30, 2023